[en] Leukemia inhibitory factor (LIF) promotes the survival of oligodendrocytes (OLG) both in vitro and in an animal model of multiple sclerosis. Here, we show that LIF protects mature rat OLG cultures selectively against the combined insult of the proinflammatory cytokines interferon-gamma and tumor necrosis factor-alpha, but it does not protect against oxidative stress nor against staurosporine induced apoptosis. We further demonstrate that LIF activates the janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) and the phosphatidylinositol 3 kinase/Akt pathway in mature OLG. We show that LIF protection is independent of suppressors of cytokine signaling and Bcl-2 mRNA expression levels. To gain further insight into the protective mechanism, a quantitative proteomic approach (DIGE) was applied to identify differentially expressed proteins in LIF-treated OLG. Our results indicate that LIF induces a shift in the cellular machinery toward a prosurvival execution program, illustrated by an enhanced expression of isoforms of the antiapoptotic molecule 14-3-3. These data provide further insight into the mechanisms of LIF-mediated protection of mature OLGs.
Buntinx, M., Moreels, M., Vandenabeele, F., Lambrichts, I. et al., Cytokine-induced cell death in human Oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 2004, 76, 834-845.
Vanderlocht, J., Hellings, N., Hendriks, J. J., Vandenabeele, F. et al., Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis. J. Neurosci. Res. 2006, 83, 763-774.
Zhang, X., Haaf, M., Todorich, B., Grosstephan, E. et al., Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 2005, 52, 199-208.
Imitola, J., Chitnis, T., Khoury, S. J., Cytokines in multiple sclerosis: From bench to bedside. Pharmacol. Ther. 2005, 106, 163-177.
Hellings, N., Gelin, G., Medaer, R., Bruckers, L. et al., Long-itudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: Association with clinical and MRI activity. J. Neuroimmunol. 2002, 126, 143-160.
Karadottir, R., Attwell, D., Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145, 1426-1438.
Rus, H., Cudrici, C., Niculescu, F., Shin, M. L., Complement activation in autoimmune demyelination: Dual role in neuroinflammation and neuroprotection. J. Neuroimmunol. 2006, 180, 9-16.
Buntinx, M., Stinissen, P., Steels, P., Ameloot, M. et al., Immune-mediated oligodendrocyte injury in multiple sclerosis: Molecular mechanisms and therapeutic interventions. Crit Rev. Immunol. 2002, 22, 391-424.
Smith, K. J., Kapoor, R., Felts, P. A., Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol. 1999, 9, 69-92.
Mayer, M., Bhakoo, K., Noble, M., Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120, 143-153.
Azari, M. F., Profyris, C., Karnezis, T., Bernard, C. C. et al., Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J. Neuropathol. Exp. Neurol. 2006, 65, 914-929.
Butzkueven, H., Emery, B., Cipriani, T., Marriott, M. P. et al., Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 2006, 53, 696-703.
Vanderlocht, J., Hendriks, J. J., Venken, K., Stinissen, P. et al., Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. J. Neuroimmunol. 2006, 177, 189-200.
Butzkueven, H., Zhang, J. G., Soilu-Hanninen, M., Hochrein, H. et al., LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8, 613-619.
Linker, R. A., Maurer, M., Gaupp, S., Martini, R. et al., CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8, 620-624.
Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M. et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374, 1-20.
Magni, P., Dozio, E., Ruscica, M., Watanobe, H. et al., Leukemia inhibitory factor induces the chemomigration of immortalized gonadotropin-releasing hormone neurons through the independent activation of the Janus kinase/signal transducer and activator of transcription 3, mitogen-activated protein kinase/extracellularly regulated kinase 1/2, and phosphatidylinositol 3-kinase/Akt signaling pathways. Mol. Endocrinol. 2007, 21, 1163-1174.
Auernhammer, C. J., Chesnokova, V., Bousquet, C., Melmed, S., Pituitary corticotropin SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol. Endocrinol. 1998, 12, 954-961.
Duval, D., Reinhardt, B., Kedinger, C., Boeuf, H., Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival. FASEB J. 2000, 14, 1577-1584.
Karlsen, A. E., Ronn, S. G., Lindberg, K., Johannesen, J. et al., Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma-mediated toxicity. Proc. Natl. Acad. Sci. USA 2001, 98, 12191-12196.
Kimura, A., Naka, T., Nagata, S., Kawase, I. et al., SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. Int. Immunol. 2004, 16, 991-999.
Battle, T. E., Frank, D. A., The role of STATs in apoptosis. Curr. Mol. Med. 2002, 2, 381-392.
Grad, J. M., Zeng, X. R., Boise, L. H., Regulation of Bcl-xL: A little bit of this and a little bit of STAT. Curr. Opin. Oncol. 2000, 12, 543-549.
Nielsen, M., Kaestel, C. G., Eriksen, K. W., Woetmann, A. et al., Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999, 13, 735-738.
Stephanou, A., Brar, B. K., Knight, R. A., Latchman, D. S., Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death. Differ. 2000, 7, 329-330.
Buntinx, M., Gielen, E., Van Hummelen, P., Raus, J. et al., Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J. Neurosci. Res. 2004, 76, 846-861.
Dumont, D., Noben, J. P., Moreels, M., Vanderlocht, J. et al., Characterization of mature rat oligodendrocytes: A proteomic approach. J. Neurochem. 2007,
Douette, P., Navet, R., Gerkens, P., de Pauw, E. et al., Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4, 2024-2031.
Dumont, D., Noben, J. P., Raus, J., Stinissen, P. et al., Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4, 2117-2124.
Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometry sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
Meiring, H. D., van der Heeft, E., ten Hove, G. J., De Jong, A. P. J. M., Nanoscale LC-MS(n): Technical design and applications to peptide and protein analysis. J. Sep. Sci. 2002, 25, 557-568.
Benjamins, J. A., Nedelkoska, L., George, E. B., Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem. Res. 2003, 28, 143-152.
Mronga, T., Stahnke, T., Goldbaum, O., Richter-Landsberg, C., Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia 2004, 46, 446-455.
Emery, B., Butzkueven, H., Snell, C., Binder, M. et al., Oligodendrocytes exhibit selective expression of suppressor of cytokine signaling genes and signal transducer and activator of transcription 1 independent inhibition of interferon-gamma-induced toxicity in response to leukemia inhibitory factor. Neuroscience 2006, 137, 463-472.
Lee, N., Neitzel, K. L., Devlin, B. K., MacLennan, A. J., STAT3 phosphorylation in injured axons before sensory and motor neuron nuclei: Potential role for STAT3 as a retrograde signaling transcription factor. J. Comp. Neurol. 2004, 474, 535-545.
Schweizer, U., Gunnersen, J., Karch, C., Wiese, S. et al., Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol. 2002, 156, 287-297.
Maier, K., Rau, C. R., Storch, M. K., Sattler, M. B. et al., Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats. Brain Pathol. 2004, 14, 378-387.
Bowman, T., Garcia, R., Turkson, J., Jove, R., STATs in oncogenesis. Oncogene 2000, 19, 2474-2488.
Barres, B. A., Schmid, R., Sendnter, M., Raff, M. C., Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118, 283-295.
Emery, B., Cate, H. S., Marriott, M., Merson, T. et al., Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc. Natl. Acad. Sci. USA 2006, 103, 7859-7864.
Negoro, S., Oh, H., Tone, E., Kunisada, K. et al., Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 2001, 103, 555-561.
Hobom, M., Storch, M. K., Weissen, R., Maier, K. et al., Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004, 14, 148-157.
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z. et al., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96, 857-868.
Datta, S. R., Dudek, H., Tao, X., Masters, S. et al., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241.
Masters, S. C., Subramanian, R. R., Truong, A., Yang, H. et al., Survival-promoting functions of 14-3-3 proteins. Biochem. Soc. Trans. 2002, 30, 360-365.
Rosenquist, M., 14-3-3 proteins in apoptosis. Braz. J. Med. Biol. Res. 2003, 36, 403-408.
Berg, D., Holzmann, C., Riess, O., 14-3-3 proteins in the nervous system. Nat. Rev. Neurosci. 2003, 4, 752-762.
Sattler, M. B., Merkler, D., Maier, K., Stadelmann, C. et al., Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death. Differ. 2004, 11, S181-S192.
Chong, Z. Z., Maiese, K., Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity. Br. J. Pharmacol. 2007, 150, 839-850.
Subramanian, R. R., Zhang, H., Wang, H., Ichijo, H. et al., Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. Exp. Cell Res. 2004, 294, 581-591.
Fanger, G. R., Widmann, C., Porter, A. C., Sather, S. et al., 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 1998, 273, 3476-3483.
Adam, L. P., Hathaway, D. R., Identification of mitogen-activated protein kinase phosphorylation sequences in mammalian h-Caldesmon. FEBS Lett. 1993, 322, 56-60.
Suh, K. S., Mutoh, M., Gerdes, M., Crutchley, J. M. et al., Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res. 2005, 65, 562-571.
Han, S., Zhang, K. H., Lu, P. H., Xu, X. M., Effects of annexins II and V on survival of neurons and astrocytes in vitro. Acta Pharmacol. Sin. 2004, 25, 602-610.
Reutelingsperger, C. P., van Heerde, W. L., Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol. Life Sci. 1997, 53, 527-532.
MacKeigan, J. P., Clements, C. M., Lieh, J. D., Pope, R. M. et al., Proteomic profiling drug-induced apoptosis in nonsmall cell lung carcinoma: Identification of RS/DJ-1 and RhoG-DIalpha. Cancer Res. 2003, 63, 6928-6934.
Zhang, B., Zhang, Y., Dagher, M. C., Shacter, E., Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 2005, 65, 6054-6062.